Development and Characterization of Microstructured, Spray-Dried Co-Amorphous Mixture of Antidiabetic Agents Stabilized by Silicate
- 33 Downloads
In the present work, co-amorphous mixture (COAM) of poorly soluble nateglinide (NT) and highly soluble Metformin hydrochloride (MT) was prepared by spray drying method to improve the dissolution rate of NT and the processability of COAM. Binary spray-dried COAM of NT and MT (120 mg: 500 mg) was prepared in its clinical dose ratio whereas 20% Neusilin®US2 (NS) was added to prepare non-sticky, free flowing ternary COAM. Solubility studies of binary and ternary COAM exhibited sevenfold and tenfold rise in the solubility of NT. Complete amorphization of NT was revealed in XRPD and DSC studies of both COAM and hydrogen-bonding interactions were reflected in FTIR-spectra. SEM microphotographs illustrated round-shaped microparticles in ternary COAM against the irregular particles in binary COAM. In vitro dissolution of NT was significantly improved in ternary COAM > binary COAM > NT irrespective of dissolution medium. On contrary, MT has partially transformed to the amorphous form in COAM without altering the solubility. In accelerated stability studies, NT and MT devitrification was not observed in XRPD of ternary COAM in contrast to binary COAM. Therefore, enhanced dissolution of NT, stabilization of spray-dried dispersion, and its improved processability can be achieved by preparing ternary COAM of NT:MT:NS.
KEY WORDSCo-amorphous mixture enhanced dissolution improved processability nateglinide stabilization of amorphous form
Authors are thankful to Tata Institute of Fundamental Research (TIFR), India for assistance on XRPD and SEM analysis. The authors are highly thankful to Cipla Ltd., India, and Sanofi Ltd., India for providing gift sample of nateglinide and metformin hydrochloride respectively.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 5.Khougaz K, Clas SD. Crystallization inhibition in solid dispersions of MK-0591 and poly (vinylpyrrolidone) polymers. J Pharm Sci. 2000;89(10):1325–34. https://doi.org/10.1002/1520-6017(200010)89:10<1325::AID-JPS10>3.0.CO;2-5.CrossRefPubMedGoogle Scholar
- 6.Gao Y, Liao J, Qi X, Zhang J. Coamorphous repaglinide–saccharin with enhanced dissolution. Int J Pharm. 2013;450(1–2):290–5. https://doi.org/10.1016/j.ijpharm.2013.04.032.
- 8.Lenz E, Jensen KT, Blaabjerg LI, Knop K, Grohganz H, Löbmann K, et al. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin–arginine. Eur J Pharm Biopharm. 2015;96:44–52. https://doi.org/10.1016/j.ejpb.2015.07.011.
- 10.Löbmann K, Strachan C, Grohganz H, Rades T, Korhonen O, Laitinen R. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. Eur J Pharm Biopharm. 2012;81(1):159–69. https://doi.org/10.1016/j.ejpb.2012.02.004.
- 12.Maggi L, Bruni G, Maietta M, Canobbio A, Cardini A, Conte U. II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling. Int J Pharm. 2013;454(1):568–72. https://doi.org/10.1016/j.ijpharm.2013.06.085.
- 14.Wairkar S, Gaud R. Co-amorphous combination of nateglinide-metformin hydrochloride for dissolution enhancement. AAPS PharmSciTech. 2016;17(3):673–81. https://doi.org/10.1208/s12249-015-0371-4.
- 16.Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness, 3rd ed. Oxford: Blackwell Science; 1998.Google Scholar
- 17.Rawlinson CF, Williams AC, Timmins P, Grimsey I. Polymer-mediated disruption of drug crystallinity. Int J Pharm. 2007;336(1):42–8. https://doi.org/10.1016/j.ijpharm.2006.11.029.
- 25.Allesø M, Chieng N, Rehder S, Rantanen J, Rades T, Aaltonen J. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen–cimetidine mixtures prepared by mechanical activation. J Control Release. 2009;136(1):45–53. https://doi.org/10.1016/j.jconrel.2009.01.027.
- 26.Remko M. Theoretical study of molecular structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some hypoglycemic agents. J Mol Struct THEOCHEM. 2009;897(1–3):73–82. https://doi.org/10.1016/j.theochem.2008.11.021.
- 27.Wairkar S, Gaud R, Jadhav N. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental ph-regulated ternary solid dispersion: in-vitro and in-vivo evaluation. J Pharm Pharmacol. 2017;69(9):1099–109. https://doi.org/10.1111/jphp.12756.
- 28.Gao P, Shi Y. Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs. AAPS J. 2012;14(4):703–13. https://doi.org/10.1208/s12248-012-9389-7.